|Articles|July 1, 2016
- Pharmaceutical Executive-07-01-2016
- Volume 36
- Issue 7
Pharmaceutical Executive, July 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Keeper of the Name: Bayer's Habib Dablealmost 10 years ago
Worlds Beyond the Clinicalmost 10 years ago
'PRIME' Time for Medicines in the EUalmost 10 years ago
Pill Countersalmost 10 years ago
Country Report: Italy, Part 2Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Amgen’s Tarlatamab Approved in China
2
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
3
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
4
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
5